Chester County News and Community Website
West Pharmaceutical Services, Inc. (NYSE: WST), headquartered in Exton, PA, is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) will present at two investor conferences in May and June, with webcasts available through its investor relations website.
West Pharmaceutical to Present at May, June Investor Conferences Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) reported first-quarter 2026 net sales of $844.9 million and diluted earnings per share of $1.92, reflecting increases of 21.0% and 56.1%, …
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will release first-quarter 2026 financial results before markets open Thursday, April 23, and will host a conference call at …
West Pharmaceutical Services to Report Q1 Results April 23 Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) has opened a 165,000-square-foot expansion at its Damastown site in Dublin to increase contract manufacturing capacity for high-volume injectable therapies, including …
West Pharmaceutical Opens Dublin Expansion to Boost Capacity Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) said President, Chief Executive Officer and Chair Eric M. Green plans to retire once a successor is appointed, with the transition …
West CEO Eric Green Plans Retirement Pending Successor Search Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will participate in two investor conferences in March, including the Barclays Global Healthcare Conference and the KBCM Healthcare Forum.
West Pharmaceutical Services to Present at Two Healthcare Conferences Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) said its board of directors declared a quarterly dividend of $0.22 per share and authorized a new share repurchase program of …
West Pharmaceutical Declares Dividend, Authorizes $1B Buyback Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) reported fourth-quarter net sales of $805.0 million and full-year net sales of $3.074 billion for 2025, both increases from the prior …
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will report fourth-quarter and full-year 2025 financial results before the market opens Thursday, February 12, 2026, setting the stage …
West Pharma Sets February Earnings Reveal as Investors Await 2025 Results Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that it has entered into a definitive agreement to sell all manufacturing and supply rights for its SmartDose® 3.5mL On-Body …
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal Read More